Previous Close | 79.19 |
Open | 79.53 |
Bid | 0.00 x 1400 |
Ask | 0.00 x 1000 |
Day's Range | 79.11 - 79.64 |
52 Week Range | 68.84 - 92.02 |
Volume | |
Avg. Volume | 6,383,474 |
Market Cap | 105.296B |
Beta (5Y Monthly) | 0.78 |
PE Ratio (TTM) | 25.17 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 2.76 (3.49%) |
Ex-Dividend Date | Mar 21, 2024 |
1y Target Est | N/A |
According to a new survey from Medtronic and Morning Consult, nearly two-thirds of U.S. adults say they'd opt for a shorter, healthier life than a longer one with health issues DUBLIN, IRELAND / ACCESSWIRE / April 19, 2024 / Americans overwhelmingly ...
Americans overwhelmingly say that when they think about longevity, it's more than just living longer—it's about living their healthiest, best lives. While most want to live to 90—well past the average U.S. life expectancy of 77.5 years—nearly two-thirds (66%) would choose a shorter, healthier life over a longer one with health issues. These findings, from a survey conducted by global healthcare technology leader Medtronic with Morning Consult, highlight a gap between U.S. adults' desire to live
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, announced the latest advancements in artificial intelligence (AI) for endoscopic care by unveiling ColonPRO™, the latest generation software for the GI Genius™ intelligent endoscopy system, along with a strategic collaboration designed to enhance patient care.